Cannell & Co. Bausch Health Companies Inc. Transaction History

Cannell & Co.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$13.31 - $20.51 $1.9 Million - $2.93 Million	-143,050 Closed	0 $0
Q1 2020 May 05, 2020	BUY	$12.98 - $30.25 $283,613 - $660,962	21,850 Added 18.03%	143,050 $2.22 Million
Q4 2019 Feb 10, 2020	SELL	$18.89 - $31.89 $21.3 Million - $36 Million	-1,127,390 Reduced 90.29%	121,200 $3.63 Million
Q3 2019 Nov 12, 2019	SELL	$20.88 - $25.66 $5.57 Million - $6.84 Million	-266,625 Reduced 17.6%	1,248,590 $27.3 Million
Q2 2019 Aug 12, 2019	BUY	$20.52 - $26.45 $16.5 Million - $21.2 Million	801,760 Added 112.38%	1,515,215 $38.2 Million
Q1 2019 May 14, 2019	BUY	$20.23 - $26.29 $14.4 Million - $18.8 Million	713,455 New	713,455 $17.6 Million

271

252M

5.12M

9.43M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.59B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Cannell & Co., based on Form 13F filings with the SEC.

Stay updated on Cannell & Co. with notifications on news.